OctoPlus N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 29 jun 2010 - 22:34

Statutaire naam OctoPlus N.V.

Titel OctoPlus announces agreement with a major pharmaceutical company on its controlled release technology

Bericht OctoPlus N.V. (“OctoPlus” or the “Company”) (Euronext: OCTO), the drug delivery company, announces today that it has signed an agreement with Novartis relating to the use of OctoPlus’ controlled release technology.

Vorige register resultaat

Volgende register resultaat

Gerelateerde downloads

201006290000000020_OctoPlus announces agreement with a major pharmaceutical company on its controlled release technology.pdf (opens in a new window)

Datum laatste update: 23 december 2025